Table 4 An empirical approach to cholesterol-lowering therapies in patients with diabetes.
From: Designing theoretically-informed implementation interventions
There is a concern that primary care physicians are under-prescribing cholesterol-lowering therapy to patients with diabetes. |
|---|
Physicians are interviewed leading to the identification of specific barriers to this behaviour: a lack of knowledge of recent research evidence about cholesterol-lowering therapy and concerns about serious drug side-effects. |
This leads to an intervention that has two components: an educational component summarising recent relevant research evidence about cholesterol-lowering therapy and the presentation of prevalence data of the drug side-effects and their consequences. |